JamesEdwardMoonMDFACP, FIDSA

Clinical Trials

• Merozoite Surface Protein 1 Antibody Response in Asymptomatic Human Malaria Infection Start of enrollment: 2008 Sep 01

  Completed

  Not Applicable

• Evaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human Performance Start of enrollment: 2012 Feb 01

  Completed

• Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines Start of enrollment: 2012 Jan 01

  Completed

  Phase 1

• Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic Fever Start of enrollment: 2014 Jul 09

  Completed

  Phase 2

• Phase 1 Clinical Trial With Controlled Human Malaria Infection (CHMI) to Evaluate the Safety and Efficacy of the Plasmodium Falciparum Vaccine Candidate FMP012 Administered Intramuscularly With AS01B Adjuvant System in Healthy Malaria-Naïve Adults Start of enrollment: 2014 Aug 01

  Completed

  Phase 1

• A Clinical Trial of the PfSPZ Vaccine Administered by Direct Venous Inoculation in Healthy Malaria-Naïve Adults: Heterologous vs. Homologous Controlled Human Malaria Infection and Reduction in Number of Doses Start of enrollment: 2014 Jun 01

  Completed

  Phase 1

• TDENV PIV and LAV Dengue Prime-boost Strategy Start of enrollment: 2014 Dec 01

  Completed

  Phase 1

• Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001) Start of enrollment: 2014 Oct 13

  Completed

  Phase 1

• Genetic Variability in CYP2D6 in U.S Active Duty Population Start of enrollment: 2016 Jan 08

  Completed

  Phase 1

• Evaluate the Infectivity Equivalence of Current and New Lots of Plasmodium Falciparum Strain NF54 Start of enrollment: 2019 Mar 04

  Completed

  Phase 1

• A Trial For The Study of Falciparum Malaria Protein 013 Administered Via Intramuscular Injection in Healthy Adults Start of enrollment: 2020 Mar 20

  Recruiting

  Phase 1

• A Trial For The Study of Falciparum Malaria Protein 014 Administered Via Intramuscular Injection in Healthy Adults Start of enrollment: 2020 Mar 20

  Recruiting

  Phase 1

• Join now to see all